Impediments to clinical research in the United States (Q48485541)

11 February 2018

title

Impediments to clinical research in the United States (English)

1 reference

11 February 2018

main subject

United States of America

0 references

3

R M Califf

1 reference

11 February 2018

J M Kramer

1

1 reference

11 February 2018

P B Smith

series ordinal

2

1 reference

11 February 2018

language of work or name

English

0 references

publication date

8 February 2012

1 reference

11 February 2018

Clinical Pharmacology & Therapeutics

published in

1 reference

11 February 2018

volume

91

1 reference

11 February 2018

issue

3

1 reference

11 February 2018

page(s)

535-541

1 reference

11 February 2018

Bridging the gap: improving clinical development and the regulatory pathways for health products for neglected diseases

cites work

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.341

The dysregulation of human subjects research.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.341

Effect of vasodilator therapy on mortality in chronic congestive heart failure. Results of a Veterans Administration Cooperative Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.341

State of the controlled clinical trial enterprise in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.341

The paradoxical problem with multiple-IRB review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.341

Invisible barriers to clinical trials: the impact of structural, infrastructural, and procedural barriers to opening oncology clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.341

Health Insurance Portability and Accountability Act (HIPAA): must there be a trade-off between privacy and quality of health care, or can we advance both?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.341

The impact of privacy and confidentiality laws on the conduct of clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.341

Addressing missing data in clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.341

Avoidance of large biases and large random errors in the assessment of moderate treatment effects: the need for systematic overviews

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.341

Reforming the regulations governing research with human subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.341

Cardiovascular events associated with rofecoxib in a colorectal adenoma chemoprevention trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.341

Assessing the impact of protocol design changes on clinical trial performance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.341

Using research metrics to improve timelines: proceedings from the 2nd Annual CTSA clinical research management workshop

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.341

Statistical methods in the journal.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.341

Medicine residents' understanding of the biostatistics and results in the medical literature.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.341

Central Challenges Facing the National Clinical Research Enterprise

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.341

Limited capacity in US pediatric drug trials: qualitative analysis of expert interviews

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.341

Race, Medical Researcher Distrust, Perceived Harm, and Willingness to Participate in Cardiovascular Prevention Trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.341

Data standards in clinical research: gaps, overlaps, challenges and future directions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.341

Advancing research data infrastructure for patient-centered outcomes research

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.341

A point-of-care clinical trial comparing insulin administered using a sliding scale versus a weight-based regimen

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.341

The ordinary miracle of cancer clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.341

7 January 2021

Scientific evidence underlying the ACC/AHA clinical practice guidelines

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.341

7 January 2021

The effects of tissue plasminogen activator, streptokinase, or both on coronary-artery patency, ventricular function, and survival after acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.341

7 January 2021

Clinical Research and the NIH — A Report Card

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.341

7 January 2021

The cost of institutional review boards in academic medical centers

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.341

7 January 2021

Identifiers

DOI

10.1038/CLPT.2011.341

1 reference

11 February 2018

release_ttseldrubrfwleeemb72urfaom

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/ttseldrubrfwleeemb72urfaom

24 November 2022

mapped directly with Wikidata item

1 reference

11 February 2018